A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Hoffmann-La Roche
Bayer
ViroMissile, Inc.
AstraZeneca
MacroGenics
Avacta Life Sciences Ltd
Solve Therapeutics
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
Blueprint Medicines Corporation
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Travera Inc
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Numab Therapeutics AG
Gradalis, Inc.
Baxter Healthcare Corporation
Tempus AI
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Agenus Inc.
Agenus Inc.
Cyteir Therapeutics, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
NantCell, Inc.
Innolake Biopharm
Pfizer
Adaptimmune
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Pfizer
pharmaand GmbH
Hoffmann-La Roche
Kineta Inc.
Shanghai Yunying Medical Technology
Quadriga Biosciences, Inc.
MacroGenics
NKGen Biotech, Inc.
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Celgene
Daiichi Sankyo
Tocagen Inc.
Mirror Biologics, Inc.
Shenzhen BinDeBio Ltd.